Modulation of the biocatalytic activity and selectivity of CeO 2 nanozymes via atomic doping engineering.

Artificial enzymes show prospects in biomedical applications due to their stable enzymatic catalytic activity and ease of preparation. CeO 2 nanozymes represent a versatile platform showing multiple enzyme-mimicking activities, although their biocatalytic activities and selectivity are relatively poor for biomedical use. Herein, we developed Mn- and Co-doped CeO 2 nanozymes (M/CeO 2 , M = Mn or Co) via atomic engineering to achieve a significant increase in enzyme-like activity. The M/CeO 2 nanozymes exhibited outstanding peroxidase-like activity with a reaction rate about 8-10 times higher than that of CeO 2 . Importantly, the Co/CeO 2 nanozyme preferred for catalase-like activity with a 4-6-fold higher catalytic rate than CeO 2 , while the Mn/CeO 2 nanozyme had a predilection for improving the superoxide dismutase-like capacity. This indicated the selective modulation of enzyme-mimicking activities via atomic doping engineering. Cellular level experiments revealed the in vitro therapeutic effects of the nanozymes. Mn/CeO 2 and Co/CeO 2 selectively modulated the intracellular redox imbalance in lipopolysaccharide (LPS)- or H 2 O 2 -stimulated nerve cells and improved cell survival. This work provides a feasible strategy for the design of catalytically selective artificial enzymes and facilitates the widespread application of CeO 2 nanozymes in redox-related diseases.